CAM
MRNA icon

ClariVest Asset Management’s Moderna MRNA Stock Holding History

ClariVest Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$364 Hold
3
– – ﹤0.01% 819
2024
Q2 		$364 Hold
3
– – ﹤0.01% 819
2024
Q1 		$332 Buy
+3
New +$302 ﹤0.01% 837
2023
Q4 		– Sell
-4
Closed – – 930
2023
Q3 		$0 Buy
+4
New +$446 ﹤0.01% 819
2021
Q2 		– Sell
-10
Closed -$1K – 798
2021
Q1 		$1K Hold
10
– – ﹤0.01% 676
2020
Q4 		$1K Hold
10
– – ﹤0.01% 698
2020
Q3 		$1K Hold
10
– – ﹤0.01% 688
2020
Q2 		$1K Buy
+10
New +$548 ﹤0.01% 745

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ClariVest Asset Management's MRNA Position: Q3 2024 in Review

ClariVest Asset Management held its Moderna (MRNA) position steady in Q3 2024 at 3 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #819.

ClariVest Asset Management first reported a position in MRNA in Q2 2020 and has held it in 8 quarters since. The position peaked at $1K in Q1 2021. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • ClariVest Asset Management held 3 shares of Moderna worth $364 as of Q3 2024.
  • ClariVest Asset Management left its Moderna share count unchanged in Q3 2024.
  • Moderna made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #819 holding.
  • ClariVest Asset Management first reported a position in Moderna in Q2 2020 and has held it in 8 quarters since.
  • ClariVest Asset Management's Moderna position peaked at $1K in Q1 2021.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.